AnPac Bio-Medical Science Co., Ltd.
ANPC · NASDAQ
12/31/2022 | 9/30/2022 | 6/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $61,721 | $31,523 | $33,381 | $48,148 |
| - Cash | $1,870 | $7,579 | $6,890 | $462 |
| + Debt | $12,314 | $8,823 | $14,474 | $18,831 |
| Enterprise Value | $72,165 | $32,767 | $40,965 | $66,517 |
| Revenue | $437 | $6,394 | $3,245 | $1,968 |
| % Growth | -93.2% | 97% | 64.9% | – |
| Gross Profit | -$33 | $4,988 | $2,291 | $1,090 |
| % Margin | -7.6% | 78% | 70.6% | 55.4% |
| EBITDA | -$32,662 | -$21,659 | -$14,679 | -$14,899 |
| % Margin | -7,474.1% | -338.7% | -452.4% | -757.1% |
| Net Income | -$32,313 | -$20,196 | -$33,915 | -$14,900 |
| % Margin | -7,394.3% | -315.9% | -1,045.1% | -757.1% |
| EPS Diluted | -16.9 | -13.95 | -39.2 | -17.22 |
| % Growth | -21.1% | 64.4% | -127.6% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |